Xin Zhang, Xin Yu Han, Hong Fan, Cheng Nan Guo, Yi Li, Hai Li Wang, Zhen Qiu Liu, Tie Jun Zhang
{"title":"Potential mediation effect of insulin resistance on the association between iron metabolism indicators and non-alcoholic fatty liver disease","authors":"Xin Zhang, Xin Yu Han, Hong Fan, Cheng Nan Guo, Yi Li, Hai Li Wang, Zhen Qiu Liu, Tie Jun Zhang","doi":"10.1111/1751-2980.13292","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Objectives</h3>\n \n <p>Iron metabolism and insulin resistance (IR) are closely related to non-alcoholic fatty liver disease (NAFLD). However, the interplay between them on the occurrence and progression of NAFLD is not fully understood. We aimed to disentangle the crosstalk between iron metabolism and IR and explore its impact on NAFLD.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We analyzed data from the National Health and Nutritional Examination Survey (NHANES) 2017–2018 to evaluate the association between serum iron metabolism indicators (ferritin, serum iron, unsaturated iron-binding capacity [UIBC], total iron-binding capacity [TIBC], transferrin saturation, and transferrin receptor) and NAFLD/non-alcoholic steatohepatitis (NASH). Mediation analysis was conducted to explore the role of IR played in these relationship.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 4812 participants were included, among whom 43.7% were diagnosed with NAFLD and 13.2% were further diagnosed with NASH. After adjusting the covariates, the risk of NAFLD increases with increasing serum ferritin (adjusted odds ratio [aOR] 1.71, 95% confidence interval [CI] 1.37–2.14), UIBC (aOR 1.45, 95% CI 1.17–1.79), and TIBC (aOR 1.36, 95% CI 1.11–1.68). Higher levels of serum ferritin (aOR 3.70, 95% CI 2.25–6.19) and TIBC (aOR 1.69, 95% CI 1.13–2.56) were also positively associated with NASH. Participants with IR were more likely to have NAFLD/NASH. Moreover, IR-mediated efficacy accounted for 85.85% and 64.51% between ferritin and NAFLD and NASH, respectively.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Higher levels of serum ferritin and TIBC are closely associated with the occurrence of NAFLD and NASH. IR may be considered a possible link between NAFLD or NASH and increased serum ferritin levels.</p>\n </section>\n </div>","PeriodicalId":15564,"journal":{"name":"Journal of Digestive Diseases","volume":"25 5","pages":"285-297"},"PeriodicalIF":2.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Digestive Diseases","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1751-2980.13292","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
Iron metabolism and insulin resistance (IR) are closely related to non-alcoholic fatty liver disease (NAFLD). However, the interplay between them on the occurrence and progression of NAFLD is not fully understood. We aimed to disentangle the crosstalk between iron metabolism and IR and explore its impact on NAFLD.
Methods
We analyzed data from the National Health and Nutritional Examination Survey (NHANES) 2017–2018 to evaluate the association between serum iron metabolism indicators (ferritin, serum iron, unsaturated iron-binding capacity [UIBC], total iron-binding capacity [TIBC], transferrin saturation, and transferrin receptor) and NAFLD/non-alcoholic steatohepatitis (NASH). Mediation analysis was conducted to explore the role of IR played in these relationship.
Results
A total of 4812 participants were included, among whom 43.7% were diagnosed with NAFLD and 13.2% were further diagnosed with NASH. After adjusting the covariates, the risk of NAFLD increases with increasing serum ferritin (adjusted odds ratio [aOR] 1.71, 95% confidence interval [CI] 1.37–2.14), UIBC (aOR 1.45, 95% CI 1.17–1.79), and TIBC (aOR 1.36, 95% CI 1.11–1.68). Higher levels of serum ferritin (aOR 3.70, 95% CI 2.25–6.19) and TIBC (aOR 1.69, 95% CI 1.13–2.56) were also positively associated with NASH. Participants with IR were more likely to have NAFLD/NASH. Moreover, IR-mediated efficacy accounted for 85.85% and 64.51% between ferritin and NAFLD and NASH, respectively.
Conclusion
Higher levels of serum ferritin and TIBC are closely associated with the occurrence of NAFLD and NASH. IR may be considered a possible link between NAFLD or NASH and increased serum ferritin levels.
目的:铁代谢和胰岛素抵抗(IR)与非酒精性脂肪肝(NAFLD)密切相关。然而,它们之间的相互作用对非酒精性脂肪肝的发生和发展的影响尚未完全明了。我们旨在厘清铁代谢与 IR 之间的相互关系,并探讨其对非酒精性脂肪肝的影响:我们分析了2017-2018年美国国家健康与营养调查(NHANES)的数据,以评估血清铁代谢指标(铁蛋白、血清铁、不饱和铁结合能力[UIBC]、总铁结合能力[TIBC]、转铁蛋白饱和度和转铁蛋白受体)与非酒精性脂肪肝/非酒精性脂肪性肝炎(NASH)之间的关联。研究人员进行了中介分析,以探讨 IR 在这些关系中的作用:共纳入 4812 名参与者,其中 43.7% 被诊断为非酒精性脂肪肝,13.2% 被进一步诊断为非酒精性脂肪性肝炎。调整协变量后,非酒精性脂肪肝的风险随着血清铁蛋白(调整后的几率比 [aOR] 1.71,95% 置信区间 [CI] 1.37-2.14)、UIBC(aOR 1.45,95% CI 1.17-1.79)和 TIBC(aOR 1.36,95% CI 1.11-1.68)的增加而增加。较高水平的血清铁蛋白(aOR 3.70,95% CI 2.25-6.19)和TIBC(aOR 1.69,95% CI 1.13-2.56)也与NASH呈正相关。患有 IR 的参与者更有可能患有 NAFLD/NASH。此外,铁蛋白与非酒精性脂肪肝和NASH之间的IR介导效应分别占85.85%和64.51%:结论:较高水平的血清铁蛋白和TIBC与非酒精性脂肪肝和NASH的发生密切相关。IR可被视为非酒精性脂肪肝或NASH与血清铁蛋白水平升高之间的可能联系。
期刊介绍:
The Journal of Digestive Diseases is the official English-language journal of the Chinese Society of Gastroenterology. The journal is published twelve times per year and includes peer-reviewed original papers, review articles and commentaries concerned with research relating to the esophagus, stomach, small intestine, colon, liver, biliary tract and pancreas.